The California Stem Cell Report

Share this post

User's avatar
The California Stem Cell Report
FTCR: Affordable Therapy, Strong Public Oversight, Diverse Research

FTCR: Affordable Therapy, Strong Public Oversight, Diverse Research

David Jensen's avatar
David Jensen
Oct 31, 2005
∙ Paid

Share this post

User's avatar
The California Stem Cell Report
FTCR: Affordable Therapy, Strong Public Oversight, Diverse Research
Share

Publicly financed stem cell research may be a "gold mine" for biotech companies, but California taxpayers should not "get the shaft," the California Foundation for Taxpayer and Consumer Rights said today.

Jerry Flanagan, health care policy director for the group, said in a statement that the California stem cell agency should ensure that taxpayers and pa…

Keep reading with a 7-day free trial

Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 David Jensen
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share